These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 16221103

  • 1. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 2. Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey EM, Abdou SH, Shareef MM.
    Clin Exp Nephrol; 2010 Jun; 14(3):214-21. PubMed ID: 20169461
    [Abstract] [Full Text] [Related]

  • 3. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 4. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 5. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov 04; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr 04; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 7. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A, Hada R, Agrawal RK, Bhattarai GR, Baral A.
    BMC Nephrol; 2018 Jul 11; 19(1):175. PubMed ID: 29996800
    [Abstract] [Full Text] [Related]

  • 8. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Jul 11; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis.
    Gadakchi L, Hajialilo M, Nakhjavani MR, Abedi Azar S, Kolahi S, Gojazadeh M, Ebrahimi AA, Malek Mahdavi A, Noshad H, Khabbazi A.
    Iran J Kidney Dis; 2018 Oct 11; 12(5):288-292. PubMed ID: 30367020
    [Abstract] [Full Text] [Related]

  • 10. Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.
    Tang Z, Yang G, Yu C, Yu Y, Wang J, Hu W, Zeng C, Chen H, Liu Z, Li L.
    Nephrology (Carlton); 2008 Dec 11; 13(8):702-7. PubMed ID: 18771470
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 11; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 12. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr 11; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
    Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D, Aspreva Lupus Management Study Group.
    J Am Soc Nephrol; 2009 May 24; 20(5):1103-12. PubMed ID: 19369404
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S, Gupta D, Ali S, Gupta P.
    Saudi J Kidney Dis Transpl; 2017 May 24; 28(5):1069-1077. PubMed ID: 28937065
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: a subgroup analysis of the Aspreva Lupus Management Study.
    Walsh M, Solomons N, Lisk L, Jayne DR.
    Am J Kidney Dis; 2013 May 24; 61(5):710-5. PubMed ID: 23375819
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN.
    N Engl J Med; 2000 Oct 19; 343(16):1156-62. PubMed ID: 11036121
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Oct 19; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 19. Treatment of lupus nephritis by mycophenolate mofetil.
    Rabrenović V, Poskurica M, Kovacević Z, Nesić V, Savin M, Mitić B, Dimković N, Cucković C, Vujić D, Pljesa S, Perunicić-Peković G, Curić S, Mitić I, Ratković M, Marinković J, Jovanović D.
    Kidney Blood Press Res; 2010 Oct 19; 33(4):297-303. PubMed ID: 20664209
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.
    Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB.
    Kidney Int; 2010 Jan 19; 77(2):152-60. PubMed ID: 19890271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.